规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | MMP ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marimastat |
+++
MMP-7, IC50: 16 nM MMP-14, IC50: 3 nM |
98% | |||||||||||||||||
Ilomastat |
++++
MMP-2, Ki: 0.1 nM MMP-26, Ki: 0.36 nM |
99%+ | |||||||||||||||||
SB-3CT |
+
MMP-2, Ki: 13.9 nM MMP-9, Ki: 600 nM |
99%+ | |||||||||||||||||
Doxycycline | ✔ | 98% | |||||||||||||||||
NSC 405020 | ✔ | 98% | |||||||||||||||||
Batimastat |
+++
MMP-1, IC50: 3 nM MMP-7, IC50: 4 nM |
99%+ | |||||||||||||||||
Nobiletin | ✔ | 99% | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
描述 | PD-166793 is a potent, selective, orally active, pan-MMP inhibitor with IC50 values of 4, 7, and 8 nM for MMP-2, MMP-3, and MMP-13, respectively, and 6.0, 7.2, and 7.9 μM for MMP-1, -7, and -9, respectively. PD-166793 reduces left ventricular remodeling and dysfunction in rat models of progressive heart failure[1][2][3].PD-166793 inhibited AMPD activity in rat heart homogenates by 20% at a concentration of 0.1 μM, and significantly reduced MMP-9 activity in normal human cardiac fibroblasts at a concentration of 100 μM for 36 h[2]. |
Animal study | At a dose of 1 mg/kg/day administered by gavage daily for 10 weeks, PD-166793 largely prevented the adverse remodelling commonly seen in the aortocaval (AV) fistula model[3].Administered orally at a dose of 5 mg/kg, PD-166793 exhibited excellent pharmacokinetics in rats with a t1/2 of 43.6 hours, Cmax of 42.4 μg/mL, and an AUC0-∞ of 2,822 μg/hour/mL[1].Administered daily by gavage at a dose of 1 mg/kg, starting 2 weeks before surgery and continuing until 8 weeks after surgery, PD-166793 prevents ventricular dilatation and attenuates typical hypertrophy caused by chronic volume overload in animals[3]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.43mL 0.49mL 0.24mL |
12.13mL 2.43mL 1.21mL |
24.25mL 4.85mL 2.43mL |
CAS号 | 199850-67-4 |
分子式 | C17H18BrNO4S |
分子量 | 412.298 |
别名 | |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry,2-8°C |
溶解方案 |
DMSO: 105 mg/mL(254.67 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
动物实验配方 |